Published by Frank Prenesti on 28th October 2025
(Sharecast News) - GSK on Tuesday said its treatment for small-cell lung cancer (SCLC) had received orphan drug status from the European Medicines Agency.
URL: http://www.digitallook.com/dl/news/story/35452366/...